Targeting prices for accelerated approval drugs may have limited impact on overall drug spending 8. december 2021Medicin, Lægemidler, Virkninger & Bi-virkninger, Sundheds-emner(link-samling), Videnskabelige ArtiklerIngen kommentarerJon Ch. Henningsen